IaD [016] Humoral immune response 2024-2025

Introduction

This document provides an extensive explanation of the principles of humoral immunity, concentrating on the activation of B lymphocytes, the intricacies of antibody structure, and the diverse functions of various antibody classes. It serves as a part of the immunology curriculum at NGU School of Medicine for the academic year 2024-2025.

Learning Objectives

  • B Lymphocyte Activation: Comprehend the intricate steps and signaling pathways involved in the activation of naive B lymphocytes after encountering antigens.

  • Role of T Cells: Understand the critical assistance provided by T helper cells in the activation process of B cells.

  • Antibody Structure: Delve into the detailed structure of antibodies, including the different classes and their specific functions in immune responses.

Immune Defense Mechanisms

First Line of Defense

  • Barrier Mechanisms: The unbroken skin, mucosal membranes, and a variety of secretions (like mucus and enzymes) constitute the first protective barriers against pathogens, preventing their entry into the body.

Second Line of Defense

  • Natural Immunity: The innate immune response employs both cellular components, such as phagocytes and natural killer cells, and humoral mechanisms through proteins like complement, to identify and combat pathogens effectively.

Third Line of Defense: Acquired Immunity

  • When natural immunity is insufficient, the body activates acquired (adaptive) immunity, allowing for specific recognition and targeted response to distinct antigens.

  • Active Immunity: Involves the production of antibodies by the host, usually following exposure to an antigen or through vaccination, leading to long-lasting immunity.

  • Passive Immunity: Refers to the temporary receipt of antibodies from an external source, such as maternal antibodies transferred to the fetus or through immunoglobulin therapy.

Humoral Immunity

Definition

Humoral immunity encapsulates the mechanisms wherein B lymphocytes secrete antibodies (immunoglobulins) to eliminate extracellular microbes, demonstrating specificity and adaptability to diverse pathogens.

Antibody Production

Only B cells have the capability to produce antibodies that are glycoproteins, specifically tailored to recognize antigens.

B Cell Activation

Two Signals for Naive B Cell Activation

  1. Signal 1: Originates from the engagement of the B cell receptor (BCR) with its specific antigen.

  2. Signal 2: Arises from a crucial interaction with T helper cells, facilitating the full activation and proliferation of the B cells.

Antigen Processing and Presentation

B cells are capable of internalizing antigens, processing them into peptide fragments, and presenting these peptides on MHC II molecules for recognition by T helper cells, which is essential for B cell activation.

B Cell Interaction with T Cells

The interaction is characterized by:

  • Binding of the MHC II-peptide complex to T cell receptors (TCR)

  • Interaction of CD40 on B cells with CD40L on activated T helper cells, which is imperative for providing the necessary stimulation for B cell activation and differentiation toward antibody-secreting plasma cells.

Cytokine Influence

T helper cells release a variety of cytokines, including IL-4, IL-5, IL-6, and IL-10, which are crucial in stimulating B cell activation, proliferation, and class switching during the immune response.

Antibody Structure and Function

Basic Structure

An antibody (immunoglobulin) is composed of four polypeptide chains, comprising:

  • Two identical light chains

  • Two identical heavy chains, creating a distinct Y-shaped structure that is essential for its function.

Functional Regions

  • Fab Region: Contains the variable regions of the antibody that are responsible for binding specifically to respective antigens, termed epitopes.

  • Paratope: The precise site on the antibody that interacts with the antigen’s epitope, ensuring specificity.

Affinity and Avidity

  • Affinity: Refers to the strength of binding between a single antibody’s Fab region and its specific epitope, crucial for effective immune responses.

  • Avidity: Represents the cumulative strength of binding when an antibody interacts with multiple identical epitopes on multivalent antigens, enhancing the overall effectiveness of the immune response.

Classes of Antibodies (Isotypes)

  • IgG: The most prevalent antibody in the bloodstream and extracellular fluid, integral in secondary immune responses and opsonization.

  • IgA: Predominantly found in mucosal areas such as the gastrointestinal and respiratory tracts, playing a vital role in mucosal immunity.

  • IgM: The first antibody class produced during primary immune responses, essential for early defense against infections.

  • IgD: Primarily functions as a B cell receptor on the surface of B cells, playing a role in the activation and differentiation of these cells.

  • IgE: Involved in mediating allergic reactions and the body’s defense against parasitic infections by binding to mast cells and basophils and triggering histamine release.

Functions of Antibodies

  • Opsonization: Enhances phagocytosis by marking pathogens for destruction by immune cells.

  • Agglutination: Facilitates clumping of antigens, preventing their mobility and spread within the body.

  • Neutralization: Blocks pathogen attachment to host cells, effectively preventing infection from occurring.

  • Complement Activation: Triggers the complement cascade, leading to the formation of a membrane attack complex, resulting in pathogen lysis.

  • Antibody-dependent Cellular Cytotoxicity (ADCC): Enables natural killer (NK) cells to destroy antibody-coated cells, providing a layer of immune defense without phagocytosis.

Primary and Secondary Immune Responses

Primary Response

Characterized by clonal selection, where B cells are activated, undergo clonal expansion, and produce specific antibodies upon first exposure to an antigen, establishing memory.

Secondary Response

Proceeds with greater speed and intensity due to the presence of memory cells from the primary encounter, demonstrating class switching that leads to the production of IgG, IgA, or IgE, which are more effective at neutralizing the pathogen.

Immunoglobulin Specifics

  • Immunoglobulin D (IgD): Plays a lesser-known role as a receptor on mature B cells, constituting less than 1% of the total circulating immunoglobulin in humans, and is crucial for B cell activation.

  • Immunoglobulin A (IgA): Acts as a critical factor in mucosal immunity, found in high concentrations in secretions such as saliva, tears, and breast milk, providing local defense in epithelial tissues.

  • Immunoglobulin E (IgE): Predominantly involved in allergic reactions and immune responses to parasites, responsible for hypersensitivity reactions by releasing histamines and other mediators from mast cells and basophils.

Suggested Reading

  • BIOS Instant Notes in Immunology - 3rd edition by PM Lydyard, A Whelan, MW Fanger.

  • Essential Immunology by Delves PJ, Martin SJ, Burton DR, Roitt IM.

  • Immunology - 2nd edition by Lippincott Williams & Wilkins.

Conclusion

This comprehensive overview delves deeply into the mechanisms of humoral immunity, underscoring the significance of B cells, antibodies, and their intricate interactions in the body’s offense against pathogens, highlighting the essential role of a well-coordinated immune response in overall health and disease management.

Here are 15 Sample Clinical Case-Based Multiple-Choice Questions (SBA) related to humoral immunity:

1. Case 1: A 5-year-old boy presents with recurrent respiratory infections. Lab tests show low serum IgG levels.

What is the most likely immunological defect?A) Hyper-IgM syndromeB) Common variable immunodeficiencyC) Severe combined immunodeficiencyD) IgA deficiencyE) X-linked agammaglobulinemiaAnswer: B) Common variable immunodeficiency

2. Case 2: A 30-year-old woman develops urticaria and wheezing after eating shellfish. Her serum shows elevated IgE levels.

What is the underlying mechanism for her symptoms?A) AutoimmunityB) Allergic reactionC) Infection responseD) MalignancyE) Genetic mutationAnswer: B) Allergic reaction

3. Case 3: A 70-year-old male receives a pneumonia vaccine and later develops pneumonia.

Why might the vaccine have been ineffective?A) Age-related immunosenescenceB) Improper vaccine storageC) Type of vaccineD) Genetic predispositionE) All of the aboveAnswer: A) Age-related immunosenescence

4. Case 4: A newborn exhibits weak respiratory drive and is diagnosed with congenital immunodeficiency.

What is the likely cause of the immunodeficiency?A) Maternal IgG transferB) Failure to produce IgMC) Lack of T cell helpD) IgA deficiencyE) Genetic mutationAnswer: A) Maternal IgG transfer

5. Case 5: A laboratory worker accidentally pricks her finger with a needle containing HIV-infected blood. She is treated with post-exposure prophylaxis.

Which type of immunity does post-exposure prophylaxis represent?A) Active immunityB) Passive immunityC) Innate immunityD) Adaptive immunityE) Natural immunityAnswer: B) Passive immunity

6. Case 6: An athlete is surprisingly diagnosed with an autoimmune disease characterized by excessive antibody production against self-antigens.

What type of B-cell activation mostly contributes to this condition?A) T-independent activationB) T-dependent activationC) HypermutationD) Class switchingE) Somatic recombinationAnswer: B) T-dependent activation

7. Case 7: A patient with recurrent infections shows elevated IgM and no IgG. Flow cytometry reveals a lack of CD19.

What condition does this most likely indicate?A) Chronic granulomatous diseaseB) X-linked agammaglobulinemiaC) Hyper-IgM syndromeD) Selective IgM deficiencyE) Marchiafava-Bignami diseaseAnswer: C) Hyper-IgM syndrome

8. Case 8: A child presents with diarrhea, weight loss, and frequent respiratory infections. Lab results show only 10% of normal serum IgA.

What immune component is primarily deficient?A) IgGB) IgMC) IgAD) IgEE) Complement proteinsAnswer: C) IgA

9. Case 9: An elderly patient with chronic illness receives a new vaccine designed to boost immunity against streptococcal infections.

What type of immunity does this vaccine aim to stimulate?A) Passive immunityB) Humoral immunityC) Cellular immunityD) Innate immunityE) Specific immunityAnswer: B) Humoral immunity

10. Case 10: A patient shows signs of hemolytic anemia after receiving blood transfusion from an incompatible donor.

What type of antibodies attack red blood cells in this situation?A) IgGB) IgAC) IgMD) IgEE) IgDAnswer: C) IgM

11. Case 11: A mother reports that her child has a persistent cough and colds. Testing reveals a deficiency in the antibody response to polysaccharide antigens.

What is the likely cause of the symptoms?A) IgG class switch failureB) Suboptimal T-cell functionC) Staphylococcal infectionD) IgE hyperactivityE) Complement deficiencyAnswer: A) IgG class switch failure

12. Case 12: A clinical trial tests a new vaccine that enhances the body's ability to produce a robust secondary immune response.

Which type of immune memory is most actively developed by this vaccine?A) Innate memoryB) Adaptive memoryC) Immediate memoryD) Long-term immunological memoryE) Humeral memoryAnswer: D) Long-term immunological memory

13. Case 13: A lab technician notices an increased production of antibody-secreting plasma cells in response to specific antigens.

What process is primarily responsible for the differentiation of B cells into plasma cells?A) Class switchingB) Somatic hypermutationC) T cell activationD) Clonal expansionE) OpsonizationAnswer: D) Clonal expansion

14. Case 14: A patient has elevated levels of both IgG and IgA following exposure to a virus.

What type of immune response does this indicate?A) Primary responseB) Secondary responseC) Innate responseD) Passive responseE) Active responseAnswer: B) Secondary response

15. Case 15: A research study concluded that high levels of IgG were found in patients exposed to a specific fungal infection.

What does this suggest regarding their immune status?A) They are likely experiencing an allergic reaction.B) They have established protection against re-infection.C) They are in a state of acute infection.D) They have a compromised immune system.E) They have not been vaccinated.Answer: B) They have established protection against re-infection.